Cargando…
Repurposing drugs in oncology (ReDO)—cimetidine as an anti-cancer agent
Cimetidine, the first H(2) receptor antagonist in widespread clinical use, has anti-cancer properties that have been elucidated in a broad range of pre-clinical and clinical studies for a number of different cancer types. These data are summarised and discussed in relation to a number of distinct me...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cancer Intelligence
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268104/ https://www.ncbi.nlm.nih.gov/pubmed/25525463 http://dx.doi.org/10.3332/ecancer.2014.485 |